🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pierre-Régis Burgel

Centre National de la Recherche Scientifique

ORCID: 0000-0003-0903-9828

Also affiliated with Inserm, Université Paris Cité, Hôpital Cochin, Institut Cochin

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.299Author DataRank

Indexed papers

4in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial

European Respiratory Journal(2025)10.1183/13993003.02443-2024
Top 55%
0.299DataRank
Top 55%5 citations

G.G. Einarsson, K. Deasy, Darren Dahly, Pradeep K. Singh, Peter Barry +18 more

Papers

Driven by 12 papers — median percentile 45. Top paper: “Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics”.

Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics

ERJ Open Research(2024)10.1183/23120541.00151-2024
N/A
0.902DataRank · unranked
32 citations

Pierre-Régis Burgel, Charles L. Daley, Anthony De Soyza, Charles Haworth, David T. Mauger +6 more

Sweat chloride and lung function responses to elexacaftor–tezacaftor–ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(25)00190-0
N/A
0.396DataRank · unranked
13 citations

Jennifer Da Silva, Emmanuelle Girodon, Isabelle Durieu, Martine Reynaud-Gaubert, Marlene Murris-Espin +132 more

Cystic fibrosis in the era of CFTR modulators: did the neutrophil slip through the cracks?

Journal of Leukocyte Biology(2024)10.1093/jleuko/qiad164
N/A
0.312DataRank · unranked
7 citations

Pierre-Régis Burgel, Véronique Witko-Sarsat

Cystic Fibrosis Microbiome-directed Antibiotic Therapy Trial in Exacerbations Results Stratified (CFMATTERS): results of a multicentre randomised controlled trial

European Respiratory Journal(2025)10.1183/13993003.02443-2024
Top 55%
0.299DataRank
Top 55%5 citations

G.G. Einarsson, K. Deasy, Darren Dahly, Pradeep K. Singh, Peter Barry +18 more

CFTR Modulators for the Treatment of Chronic Obstructive Pulmonary Disease: The Jury Is Still Out!

American Journal of Respiratory and Critical Care Medicine(2025)10.1164/rccm.202409-1878ed
N/A
0.241DataRank · unranked
4 citations

Pierre-Régis Burgel, Lucile Regard

Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.12.379115
N/A
0DataRank · unranked
5 citations

Flávia C. Amaral, Camila F. Souza, Daniel A. G. B. Mendes, Carlos W. S. Wanderley, Cristina B. Lorenzini +32 more

Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies after Rapid Adoption: A Dual-Approach Study

Annals of the American Thoracic Society(2025)10.1513/annalsats.202503-267oc
N/A
0DataRank · unranked
1 citations

Grace C Zhou, Weiji Su, Pierre-Régis Burgel, Elizabeth A. Cromwell, Christopher H. Goss +13 more

Guidance for chest-CT in children and adults with cystic fibrosis: A European perspective

Respiratory Medicine(2025)10.1016/j.rmed.2025.108076
N/A
0DataRank · unranked
5 citations

K. Hill, Michael Waldron, Barbara Messore, Luca Riberi, Marcus Svedberg +19 more

New concepts in antimicrobial resistance in cystic fibrosis respiratory infections

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.10.005
N/A
0DataRank · unranked
43 citations

Rafael Cantón, Helle Krogh Johansen, Lucas R. Hoffman, Tom Coenye, Pierre-Régis Burgel +2 more

Neuraminidase is a host‐directed approach to regulate neutrophil responses in sepsis and COVID‐19

British Journal of Pharmacology(2022)10.1111/bph.16013
N/A
0DataRank · unranked
20 citations

Flávia C. Amaral, Camila F. de Souza, Daniel A. G. B. Mendes, Carlos W. S. Wanderley, Cristina B. Lorenzini +32 more

Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USA

European Respiratory Journal(2024)10.1183/13993003.01146-2024
N/A
0DataRank · unranked
16 citations

J. Ostrenga, Don B. Sanders, Wayne J. Morgan, Carlo Castellani, Rhonda D. Szczesniak +2 more

European Respiratory Society clinical practice guideline for the management of adult bronchiectasis

European Respiratory Journal(2025)10.1183/13993003.01126-2025
N/A
0DataRank · unranked
89 citations

Charles Haworth, Patrick A. Flume, Merete Long, Pierre-Régis Burgel, Katerina Dimakou +25 more